The direct relationship between a high-fat, high-cholesterol diet and the elevation of atherosclerosis risk has long been acknowledged.
Nevertheless, a recent study, dissecting the mechanistic association among natural emulsifiers, gut bacteria, and atherosclerosis, sheds fresh light on the subtle pathways connecting diet to heart health.
The underpinnings unearthed, notably regarding phospholipid derivatives and intestinal cellular interactions, could potentially steer targeted interventions for those teetering on the brink of heart disease.
Phospholipids: The Subtle Culprits in the Dietary Regime
As Professor Alan Fogelman of UCLA elucidates, phospholipids, or natural emulsifiers, ubiquitously found in our diets, don’t merely maintain the stability of oil in salad dressings.
Their role transcends this superficial function, as these emulsifiers can metamorphose into potent pro-inflammatory molecules within the body, particularly when modified by specific enzymes in intestinal cells.
The Gut Microbiome and Its Cascading Implications on Heart Health
Upon exploration of a mouse model – which mirrored elevated levels of “bad cholesterol” or low-density lipoprotein in atherosclerosis patients and lacked an enzyme pivotal for pro-inflammatory derivative generation in intestinal lining cells – an intriguing pathway was revealed.
On a diet rich in fat and cholesterol, the intestinal lining cells generated reactive phospholipids, rendering the lining more prone to bacterial invasion from the gut.
Consequently, the otherwise efficient defense mechanisms of the intestinal lining cells become compromised, spurring a series of events leading to heightened inflammation and accelerated atherosclerosis.
Unraveling the Inflammation and Atherosclerosis Mechanism
The catalyst in this mechanism is endotoxin, a toxin present in bacterial cell membranes.
When defense mechanisms wane due to excessive cholesterol and fat uptake, bacteria can come in contact with the cells lining the intestines (enterocytes), resulting in increased endotoxin levels in the bloodstream, thereby elevating inflammation and hastening the development of atherosclerosis.
A Novel Approach: Harnessing “Good Cholesterol” to Combat Inflammation
The research team, cognizant of the nuanced mechanisms unearthed, explored a fascinating avenue utilizing a high-density lipoprotein mimetic, commonly recognized as “good cholesterol”.
A creation of transgenic tomatoes, which mimic this beneficial cholesterol, not only assists in reducing cholesterol and triglyceride levels but also dampens the inflammatory derivatives of the phospholipids when incorporated into a high-fat, high-cholesterol diet, according to Arnab Chattopadhyay, the lead author of the study.
Navigating Forward: Implications and Potential Interventions
This revelation of a method to lower cholesterol levels and diminish the inflammatory derivatives of phospholipids indicates a promising pathway for mitigating the risks of not only atherosclerosis but also a spectrum of inflammatory diseases such as arthritis and multiple sclerosis, especially among obese individuals.
With these findings, published in the Journal of Lipid Research, the conversation around gut health, dietary intake, and cardiovascular disease intertwines, offering a rich substrate for further research and the development of targeted dietary interventions to safeguard heart health amidst the global epidemic of obesity and related disorders.
If you care about health, please read studies that vitamin D can help reduce inflammation, and vitamin K could lower your heart disease risk by a third.
For more information about heart health, please see recent studies about new way to prevent heart attacks and strokes, and results showing this drug for heart disease may reduce COVID-19 risk.
The research findings can be found in the Journal of Lipid Research.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
